Gensight Biologics SA (EUR)
SIGHT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.09 | 3.02
52-Wk Range0.86 | 5.28
Last Close1.74
Mkt Cap (m)50.15
Dividend yield-
ISINFR0013183985
Volume4,373,249
Exchange VenuePAR

Company Profile

Gensight Biologics SA is a clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and, in the future, of the central nervous system.

Key Information
Price/Earning-
Price/Book3.27
Price/Sales-
P/CF-
Rev Growth (3 year avg)0.00
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-84.84
Debt/Equity0.14

Legal Documents

Prospectus
en 25/05/2016
Annual Report
en 31/12/2018

Financials

Income Statement
EUR201320142015201620172018
Revenue (m)
Operating Income (m)-3-7-14-22-24-33
Net Income (m)-3-7-14-22-24-33
Basic EPS-0.20-0.36-0.73-1.36-1.10-1.37
Avg. Diluted Shares Outstanding (m)181819162224
Balance Sheet
EUR201320142015201620172018
Current Assets (m)181435586135
Non Current Assets (m)111112
Total Assets (m)191536596237
Current Liabilities (m)2463410
Total Liabilities (m)------
Total Equity (m)171129535524
Cash Flows
EUR201320142015201620172018
Operating Cash Flows (m)-2-6-12-20-19-28
Capital Expenditure (m)-1-1
Figures are quoted in EUR unless stated otherwise
1.11 (63.98%)
2.85
Last Price